Search research articles
Contact Us
Filters
Showing results (21-30 of 45) with videos related to
Page
of 5
Sort By:
Journal of Comparative Effectiveness Research
|
July 15, 2015
Impact of paliperidone palmitate versus oral atypical antipsychotics on healthcare outcomes in schizophrenia patients
Yongling Xiao, Erik Muser, Marie-Hélène Lafeuille, et al.
Clinical Therapeutics
|
October 18, 2011
Health care resource utilization and costs in a commercially insured population of patients with bipolar disorder type I and frequent psychiatric interventions
Erin Bagalman, Erik Muser, Jiyoon C Choi, et al.
Journal of Medical Economics
|
September 7, 2013
Patterns of relapse and associated cost burden in schizophrenia patients receiving atypical antipsychotics
Marie-Hélène Lafeuille, Jonathan Gravel, Patrick Lefebvre, et al.
Journal of Medical Economics
|
February 29, 2024
Characterizing the real-world economic burden of metastatic castration-sensitive prostate cancer in the United States
Deborah R Kaye, Ibrahim Khilfeh, Erik Muser, et al.
Journal of Medical Economics
|
April 9, 2015
Cost effectiveness of paliperidone palmitate versus oral antipsychotics in patients with schizophrenia and a history of criminal justice involvement
Erik Muser, Chris M Kozma, Carmela J Benson, et al.
Crohn'S & Colitis 360
|
February 13, 2023
Indicators of Suboptimal Treatment and Associated Healthcare Costs Among Patients With Crohn's Disease Initiated on Biologic or Conventional Agents
Dominic Pilon, Zhijie Ding, Erik Muser, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 20, 2015
Comparison of rehospitalization rates and associated costs among patients with schizophrenia receiving paliperidone palmitate or oral antipsychotics
Marie-Hélène Lafeuille, Amanda Melina Grittner, Jonathan Fortier, et al.
Journal of Health Economics and Outcomes Research
|
September 13, 2024
Real-World Clinical Outcomes and Treatment Patterns Among Black and Non-Black Patients With Prostate Cancer Initiated on Apalutamide in a Urology Setting
Benjamin H Lowentritt, Carmine Rossi, Erik Muser, et al.
Journal of Comparative Effectiveness Research
|
September 25, 2014
Comparative effectiveness of injectable paliperidone palmitate versus oral atypical antipsychotics: early postmarketing evidence
Elaine H Morrato, Joe Parks, Elizabeth J Campagna, et al.
Journal of Managed Care & Specialty Pharmacy
|
July 1, 2024
Real-world economic burden associated with disease progression from metastatic castration-sensitive to castration-resistant prostate cancer on treatment in the United States
Deborah R Kaye, Ibrahim Khilfeh, Erik Muser, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 45) with videos related to
Sort By:
Page
of 5
Journal of Comparative Effectiveness Research
|
July 15, 2015
Impact of paliperidone palmitate versus oral atypical antipsychotics on healthcare outcomes in schizophrenia patients
Yongling Xiao, Erik Muser, Marie-Hélène Lafeuille, et al.
Clinical Therapeutics
|
October 18, 2011
Health care resource utilization and costs in a commercially insured population of patients with bipolar disorder type I and frequent psychiatric interventions
Erin Bagalman, Erik Muser, Jiyoon C Choi, et al.
Journal of Medical Economics
|
September 7, 2013
Patterns of relapse and associated cost burden in schizophrenia patients receiving atypical antipsychotics
Marie-Hélène Lafeuille, Jonathan Gravel, Patrick Lefebvre, et al.
Journal of Medical Economics
|
February 29, 2024
Characterizing the real-world economic burden of metastatic castration-sensitive prostate cancer in the United States
Deborah R Kaye, Ibrahim Khilfeh, Erik Muser, et al.
Journal of Medical Economics
|
April 9, 2015
Cost effectiveness of paliperidone palmitate versus oral antipsychotics in patients with schizophrenia and a history of criminal justice involvement
Erik Muser, Chris M Kozma, Carmela J Benson, et al.
Crohn'S & Colitis 360
|
February 13, 2023
Indicators of Suboptimal Treatment and Associated Healthcare Costs Among Patients With Crohn's Disease Initiated on Biologic or Conventional Agents
Dominic Pilon, Zhijie Ding, Erik Muser, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 20, 2015
Comparison of rehospitalization rates and associated costs among patients with schizophrenia receiving paliperidone palmitate or oral antipsychotics
Marie-Hélène Lafeuille, Amanda Melina Grittner, Jonathan Fortier, et al.
Journal of Health Economics and Outcomes Research
|
September 13, 2024
Real-World Clinical Outcomes and Treatment Patterns Among Black and Non-Black Patients With Prostate Cancer Initiated on Apalutamide in a Urology Setting
Benjamin H Lowentritt, Carmine Rossi, Erik Muser, et al.
Journal of Comparative Effectiveness Research
|
September 25, 2014
Comparative effectiveness of injectable paliperidone palmitate versus oral atypical antipsychotics: early postmarketing evidence
Elaine H Morrato, Joe Parks, Elizabeth J Campagna, et al.
Journal of Managed Care & Specialty Pharmacy
|
July 1, 2024
Real-world economic burden associated with disease progression from metastatic castration-sensitive to castration-resistant prostate cancer on treatment in the United States
Deborah R Kaye, Ibrahim Khilfeh, Erik Muser, et al.
Page
of 5